In a recent regulatory update, the Central Drugs Standard Control Organisation (CDSCO) has formally approved the withdrawal ...

Against the backdrop of global trade policy uncertainties, even the threat of high tariffs may not be able to stop the upward momentum of certain high-quality stocks. Taking pharmaceutical giant ...

Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...

Relay Therapeutics, Inc. leads with RLY-2608, an allosteric PI3Kα inhibitor showing superior safety & efficacy. Learn more ...

Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...

A major boardroom shake-up at Novo Nordisk has given the Novo Nordisk Foundation an unprecedented level of control, raising ...

Eli Lilly said Friday it is set to acquire clinical-stage company Adverum Biotechnologies for up to $12.47 a share, including milestone payments.

Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price ...

Eli Lilly and Company (NYSE: LLY) is one of the stocks Jim Cramer recently answered questions about. Answering a caller’s ...

Eli Lilly (NYSE: LLY) is part of this group. On Sept. 16, the drugmaker announced plans to build a $5 billion facility in ...

The former ‘Tonight Show’ host is also a legendary autophile. But there’s one luxury vehicle he swears he’ll never buy.